Medifast officer proposes sale of 9,544 shares

MEDIFAST INC (MED) is the issuer named in a Rule 144 notice listing a proposed sale for officer Daniel Chard’s account of 9,544 common shares on September 29, 2026, with an aggregate market value of $111,951.15.

Rhea-AI Filing Summary

MEDIFAST INC (MED) is the issuer named in a Rule 144 notice listing a proposed sale for officer Daniel Chard’s account of 9,544 common shares on September 29, 2026, with an aggregate market value of $111,951.15. The remarks say the shares are being sold from the Daniel and Allyson Chard FAM IRRVOC TR; Fidelity Brokerage Services LLC is listed as broker. The notice also lists 9,545 shares sold on September 28, 2026, with an aggregate market value of $114,337.80.

Key Figures

Shares proposed for sale: 9,544 shares Aggregate market value of proposed sale: $111,951.15 Issuer shares outstanding: 11,180,703 shares +2 more

5 metrics

Shares proposed for sale 9,544 shares Proposed sale date: September 29, 2026

Aggregate market value of proposed sale $111,951.15 Proposed sale date: September 29, 2026

Issuer shares outstanding 11,180,703 shares Count reported in the securities information

Shares sold 9,545 shares Sale listed for September 28, 2026

Aggregate market value of reported sale $114,337.80 Sale listed for September 28, 2026

Key Terms

Rule 144, Stock Award, attorney-in-fact

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Award financial

"Stock Award"

attorney-in-fact regulatory

"as attorney-in-fact for Daniel Chard"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MED shares does officer Daniel Chard plan to sell?

The notice lists a proposed sale of 9,544 common shares on September 29, 2026, with an aggregate market value of $111,951.15. Fidelity Brokerage Services LLC is listed as broker, and the remarks identify the Daniel and Allyson Chard FAM IRRVOC TR as the source of the shares.

How many MED shares did Daniel Chard sell recently?

The notice lists 9,545 common shares sold on September 28, 2026, with an aggregate market value of $114,337.80.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 03:25 PM Accepted by SEC EDGAR 09/29/2026 - 03:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001289557
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MEDIFAST INC
SEC File Number	001-31573
Address of Issuer	1501 S. CLINTON STREET SUITE 500 BALTIMORE MARYLAND 21224
Phone	4105818042
Name of Person for Whose Account the Securities are To Be Sold	Chard Daniel R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	9544	111951.15	11180703	09/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/31/2021	Stock Award	Issuer			9544	12/31/2021	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel Chard C/O MEDIFAST INC 1501 S. CLINTON STREET suite 500 Baltimore MD 21224	Common Stock	09/28/2026	9545	114337.80

144: Remarks and Signature

Remarks	shares are being sold from THE DANIEL AND ALLYSON CHARD FAM IRRVOC TR, U/A 10/12/21
Date of Notice	09/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey Skillern as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel Chard
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)